Gary Sender | Chief Financial Officer |
Ted Schroeder | Chief Executive Officer |
Francesco Maria Lavino | Chief Commercial Officer |
Jennifer Schranz | Chief Medical Officer |
Steve Gelone | President & Chief Operating Officer |
Alan Carr | Needham & Company |
Eduardo Arce | H.C. Wainwright & Co. |
Kevin Kedra | G.Research |
Ladies and gentlemen, thank you for standing by. And welcome to the Nabriva Therapeutics Second Quarter 2020 Financial Results Call. At this time, all participants are in a listen-only mode. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the call over to Mr.